12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks experienced significant movements. Virpax Pharmaceuticals, Talphera, Brainstorm Cell, NKGen Biotech, 180 Life Sciences, and ENDRA Life Sciences were among the gainers, with increases ranging from 7.14% to 12.3%. Conversely, Synaptogenix, Portage Biotech, Bright Green, Motus GI Holdings, Fresh2 Group, and Biofrontera were the losers, with their stock prices declining between 6.86% and 19.6%.
February 21, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Talphera stock increased by 9.83% to $1.34, with a market cap of $22.7 million.
Talphera's stock price rise indicates a positive market reaction, likely contributing to short-term bullish behavior.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Virpax Pharmaceuticals stock rose 12.3% to $0.34, with a market value of $4.0 million.
The significant after-market increase in VRPX's stock price suggests positive investor sentiment, potentially leading to short-term upward price momentum.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Portage Biotech shares decreased by 7.81% to $0.39, with a market value of $7.7 million.
Portage Biotech's stock price drop suggests potential negative market sentiment, which may affect its short-term price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Synaptogenix shares declined by 19.6% to $0.21, with a market value of $4.2 million.
The sharp decline in SNPX's stock price could indicate negative investor sentiment, potentially leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90